Fed. Circ. Affirms Cephalon Win In Generic Fentora IP Suit
The appeals court affirmed the lower court's ruling in a nonprecedential, per curiam decision that did not offer an explanation for the decision.
U.S. District Judge Sue L. Robinson held in March that Watson's proposed generic version of Fentora, a drug used to treat breakthrough pain in cancer patients, infringed four claims of U.S. Patent Number 6,264,981, prompting Watson to...
To view the full article, register now.